Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jul 15;200(2):258-261.
doi: 10.1164/rccm.201903-0503LE.

Type I Collagen-targeted Positron Emission Tomography Imaging in Idiopathic Pulmonary Fibrosis: First-in-Human Studies

Affiliations

Type I Collagen-targeted Positron Emission Tomography Imaging in Idiopathic Pulmonary Fibrosis: First-in-Human Studies

Sydney B Montesi et al. Am J Respir Crit Care Med. .
No abstract available

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
68Ga-CBP8 standardized uptake values (SUVs). Data are reported as box-and-whisker plots. *P < 0.05 and **P < 0.01 for subjects with idiopathic pulmonary fibrosis (IPF) compared with healthy volunteers.
Figure 2.
Figure 2.
Collagen-targeted molecular imaging using 68Ga-CBP8 positron emission tomography (PET). (A) Coronal PET image of a healthy volunteer, demonstrating low collagen tracer signal in the lungs. (B) PET image of a subject with idiopathic pulmonary fibrosis rendered on the same scale as in A, demonstrating areas of high collagen tracer signal predominantly in subpleural and basilar regions in the lungs. (C) High-resolution computed tomography (CT) of the same subject with idiopathic pulmonary fibrosis obtained within 8 weeks of PET–magnetic resonance imaging. Compared with the PET imaging (B), increased collagen tracer signal is not confined to areas of fibrosis visualized on CT. White arrows highlight regions of high tracer signal within areas of lung without apparent fibrosis on CT. Red arrows highlight regions of high tracer signal within areas of established fibrosis on CT.

References

    1. Désogère P, Tapias LF, Hariri LP, Rotile NJ, Rietz TA, Probst CK, et al. Type I collagen-targeted PET probe for pulmonary fibrosis detection and staging in preclinical models. Sci Transl Med. 2017;9:eaaf4696. - PMC - PubMed
    1. Montesi SB, Izquierdo-Garcia D, Abston E, Désogère P, Digumarthy SR, Seethamraju R, et al. Collagen-targeted PET imaging in idiopathic pulmonary fibrosis: first-in-human studies [abstract] Am J Respir Crit Care Med. 2019;199:A7349. - PMC - PubMed
    1. Montesi SB, Rao R, Liang LL, Goulart HE, Sharma A, Digumarthy SR, et al. Gadofosveset-enhanced lung magnetic resonance imaging to detect ongoing vascular leak in pulmonary fibrosis. Eur Respir J. 2018;51:1800171. - PMC - PubMed
    1. Montesi SB, Désogère P, Fuchs BC, Caravan P. Molecular imaging of fibrosis: recent advances and future directions. J Clin Invest. 2019;129:24–33. - PMC - PubMed
    1. Désogère P, Montesi SB, Caravan P. Molecular probes for imaging fibrosis and fibrogenesis. Chemistry. 2019;25:1128–1141. - PMC - PubMed

Publication types